CEOs join reg­u­la­tors and top sci­en­tists vow­ing to hold the line on Covid-19 vac­cine. But will that get in the way of Trump's 'big sur­prise'?

Nine top de­vel­op­ers lead­ing the race to de­vel­op a vac­cine to com­bat Covid-19 are pre­sent­ing a uni­fied front this morn­ing as they joint­ly com­mit to hold­ing the line on any new FDA ap­provals — in­sist­ing that any­thing that is green-light­ed for com­mer­cial use for a mass mar­ket will have to meet high stan­dards on safe­ty and ef­fi­ca­cy.

They’re join­ing top reg­u­la­tors and even the se­nior sci­en­tif­ic ad­vis­er for Op­er­a­tion Warp Speed — GSK vet Mon­cef Slaoui — who have vowed to fall on their swords rather than com­pro­mise their eth­i­cal stan­dards for some po­lit­i­cal end.

This article is for premium subscribers only

Upgrade to a premium subscription plan for unlimited access, and join our community of key biopharma players.

UPGRADE